Method Development Validation Services
From Formulation to Patient
Next Breath provides comprehensive solutions for the product development process from pharmaceutical product development and CMC testing, to finished batch release and post-approval stability for submission to regulatory agencies worldwide. Our pharma solutions offering covers metered-dose inhalers (MDIs), dry powder inhaler (DPIs), nebulizers, and nasal inhalation products. We work with our customers at each step of the method development and validation process to ensure complete customer satisfaction. Our customers rely on Next Breath’s expertise, experience and comprehensive Development Service portfolio to efficiently progress their product towards regulatory approval.